AMP‐activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP‐sensitive K+ channels
Open Access
- 16 October 2006
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 210 (1) , 224-236
Abstract
Brief periods of ischemia and reperfusion that precede sustained ischemia lead to a reduction in myocardial infarct size. This phenomenon, known as ischemic preconditioning, is mediated by signaling pathway(s) that is complex and yet to be fully defined. AMP‐activated kinase (AMPK) is activated in cells under conditions associated with ATP depletion and increased AMP/ATP ratio. In the present study, we have taken advantage of a cardiac phenotype overexpressing a dominant negative form of the α2 subunit of AMPK to analyze the role, if any, that AMPK plays in preconditioning the heart. We have found that myocardial preconditioning activates AMPK in wild type, but not transgenic mice. Cardiac cells from transgenic mice could not be preconditioned, as opposed to cells from the wild type. The cytoprotective effect of AMPK was not related to the effect that preconditioning has on mitochondrial membrane potential as revealed by JC‐1, a mitochondrial membrane potential‐sensitive dye, and laser confocal microscopy. In contrast, experiments with di‐8‐ANEPPS, a sarcolemmal‐potential sensitive dye, has demonstrated that intact AMPK activity is required for preconditioning‐induced shortening of the action membrane potential. The preconditioning‐induced activation of sarcolemmal KATP channels was observed in wild type, but not in transgenic mice. HMR 1098, a selective inhibitor of sarcolemmal KATP channels opening, inhibited preconditioning‐induced shortening of action membrane potential as well as cardioprotection afforded by AMPK. Immunoprecipitation followed by Western blotting has shown that AMPK is essential for preconditioning‐induced recruitment of sarcolemmal KATP channels. Based on the obtained results, we conclude that AMPK mediates preconditioning in cardiac cells by regulating the activity and recruitment of sarcolemmal KATP channels without being a part of signaling pathway that regulates mitochondrial membrane potential. J. Cell. Physiol. 210: 224–236, 2007.Keywords
This publication has 53 references indexed in Scilit:
- 3'phosphoinositide‐dependent kinase‐1 is essential for ischemic preconditioning of the myocardiumThe FASEB Journal, 2006
- An unexpected negative inotropic effect of prostaglandin F2α in the rat heartProstaglandins & Other Lipid Mediators, 2006
- Overexpression of SUR2A generates a cardiac phenotype resistant to ischemiaThe FASEB Journal, 2006
- High glucose protects single beating adult cardiomyocytes against hypoxiaBiochemical and Biophysical Research Communications, 2006
- Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contractionThe EMBO Journal, 2005
- AMP-Activated Protein Kinase: A Key Stress Signaling Pathway in the HeartTrends in Cardiovascular Medicine, 2005
- Role of sarcolemmal KATP channels in cardioprotection against ischemia/reperfusion injury in miceJournal of Clinical Investigation, 2002
- Reversal of the ATP-liganded State of ATP-sensitive K+ Channels by Adenylate Kinase ActivityJournal of Biological Chemistry, 1996
- Biphasic Response of Action Potential Duration to Metabolic Inhibition in Rabbit and Human Ventricular Myocytes: Role of Transient Outward Current and ATP-regulated Potassium CurrentJournal of Molecular and Cellular Cardiology, 1996
- A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ ChannelsNeuron, 1996